+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Galactosemia Market - Global Forecast 2025-2030- Product Image
Galactosemia Market - Global Forecast 2025-2030- Product Image
Sale

Galactosemia Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016541
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Galactosemia Market is experiencing notable transformation as leading healthcare stakeholders align clinical innovation, diagnostics, and advanced therapies to address the complex challenges of inherited metabolic disorders. Evolving care models and regulatory developments are shaping new growth opportunities while reinforcing the urgency for efficient, integrated solutions across global markets.

Market Snapshot: Galactosemia Market Growth

The Galactosemia Market grew from USD 531.54 million in 2024 to USD 570.45 million in 2025. It is expected to continue growing at a CAGR of 7.12%, reaching USD 803.11 million by 2030. This momentum is underpinned by advances in genetic screening, emergence of targeted therapeutics, and an expanding infrastructure for rare disease management.

Scope & Segmentation

  • Product Type
    • Diagnostic Solutions
    • Therapeutic Solutions
  • Diagnostic Modalities
    • Genetic Testing
    • Newborn Screening
  • Therapeutic Approaches
    • Dietary Management
    • Enzyme Replacement Therapy
    • Gene Therapy
    • Nutritional Supplements
  • End Users
    • Diagnostic Laboratories
    • Home Healthcare Agencies
    • Hospitals
    • Specialty Clinics
  • Distribution Channels
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Regions Covered
    • Americas: United States (including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • bioMérieux SA
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • BioMarin Pharmaceutical Inc.
    • Ultragenyx Pharmaceutical Inc.
    • Vivet Therapeutics, Inc.

Key Takeaways for Senior Decision-Makers

  • Early genetic screening and newborn testing are strengthening early intervention pathways and clinical outcomes in the galactosemia market.
  • Technological advancement, including high-throughput sequencing and digital health tools, supports more precise diagnostics and real-time patient monitoring.
  • Therapeutic strategies are shifting from traditional dietary restrictions to include enzyme replacement and emerging gene therapies, broadening treatment possibilities.
  • Regional disparities in infrastructure and regulatory policy drive variable adoption rates and access, highlighting the need for cross-regional collaboration and tailored market entry strategies.
  • Strategic alliances between diagnostic providers, therapeutic developers, and advocacy groups are accelerating product development and access to care.
  • Supply chain optimization and domestic manufacturing resilience are vital for mitigating the impacts of global policy changes on care delivery.

Tariff Impact on Galactosemia Diagnostics and Therapeutics

Planned United States tariff changes in 2025 are expected to increase costs for imported laboratory equipment and reagents. This may affect turnaround times for diagnostic services and raise prices for both diagnostics and therapeutics. Manufacturers might seek new sourcing strategies and invest in local production, while stakeholders must monitor reimbursement and supply continuity closely to maintain patient access.

Methodology & Data Sources

Insights are based on primary interviews with metabolic specialists, regulatory experts, and diagnostic laboratory leaders, supplemented by extensive review of industry data, peer-reviewed literature, and regulatory filings. Multi-stage validation processes ensure all findings are actionable and reflect real-world market dynamics.

Why This Report Matters

  • Assists senior leaders in identifying technology, policy, and collaboration trends shaping the future of galactosemia care and investment priorities.
  • Enables informed decisions on supply chain resilience, patient engagement strategies, and product portfolio expansion.
  • Guides cross-regional planning by clarifying regulatory, infrastructure, and reimbursement variances impacting growth potential.

Conclusion

The galactosemia market is evolving rapidly, driven by clinical innovation, strategic collaboration, and dynamic regulatory landscapes. Stakeholders who adapt proactively will be best positioned to enhance patient outcomes and secure sustained growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of newborn screening programs for early detection of galactosemia patients
5.2. Clinical progress and challenges in developing gene therapy approaches for galactosemia
5.3. Emerging enzyme replacement therapy candidates poised to transform galactosemia treatment landscape
5.4. Integration of digital health platforms for real-time dietary monitoring in galactosemia patients
5.5. Advancements in biomarker discovery enhancing personalized management strategies for galactosemia
5.6. Growth of patient registries enabling collaborative research and outcome tracking in galactosemia
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Galactosemia Market, by Product Type
8.1. Introduction
8.2. Diagnostic Solutions
8.2.1. Genetic Testing
8.2.2. Newborn Screening
8.3. Therapeutic Solutions
8.3.1. Dietary Management
8.3.2. Enzyme Replacement Therapy
8.3.3. Gene Therapy
8.3.4. Nutritional Supplements
9. Galactosemia Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Home Healthcare Agencies
9.4. Hospitals
9.5. Specialty Clinics
10. Galactosemia Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Americas Galactosemia Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Galactosemia Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Galactosemia Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. PerkinElmer, Inc.
14.3.2. Thermo Fisher Scientific Inc.
14.3.3. Bio-Rad Laboratories, Inc.
14.3.4. F. Hoffmann-La Roche Ltd.
14.3.5. bioMérieux SA
14.3.6. Laboratory Corporation of America Holdings
14.3.7. Quest Diagnostics Incorporated
14.3.8. BioMarin Pharmaceutical Inc.
14.3.9. Ultragenyx Pharmaceutical Inc.
14.3.10. Vivet Therapeutics, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. GALACTOSEMIA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GALACTOSEMIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GALACTOSEMIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. GALACTOSEMIA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. GALACTOSEMIA MARKET: RESEARCHAI
FIGURE 22. GALACTOSEMIA MARKET: RESEARCHSTATISTICS
FIGURE 23. GALACTOSEMIA MARKET: RESEARCHCONTACTS
FIGURE 24. GALACTOSEMIA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GALACTOSEMIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GALACTOSEMIA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GALACTOSEMIA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GALACTOSEMIA MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GALACTOSEMIA MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GALACTOSEMIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GALACTOSEMIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GALACTOSEMIA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GALACTOSEMIA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GALACTOSEMIA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GALACTOSEMIA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. CANADA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. CANADA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 76. CANADA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 77. CANADA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 78. CANADA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 79. CANADA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. CANADA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. CANADA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. CANADA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. MEXICO GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. MEXICO GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 86. MEXICO GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 87. MEXICO GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 88. MEXICO GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 89. MEXICO GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. MEXICO GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. MEXICO GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. MEXICO GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. GERMANY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. GERMANY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. GERMANY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 138. GERMANY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 139. GERMANY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 140. GERMANY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 141. GERMANY GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. GERMANY GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. GERMANY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. GERMANY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. FRANCE GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. FRANCE GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. FRANCE GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 148. FRANCE GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 149. FRANCE GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 150. FRANCE GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 151. FRANCE GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. FRANCE GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. FRANCE GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. FRANCE GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ITALY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ITALY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ITALY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 168. ITALY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 169. ITALY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 170. ITALY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 171. ITALY GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ITALY GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ITALY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. ITALY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. SPAIN GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. SPAIN GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. SPAIN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 178. SPAIN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 179. SPAIN GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 180. SPAIN GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 181. SPAIN GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. SPAIN GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. SPAIN GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. SPAIN GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. DENMARK GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. DENMARK GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. DENMARK GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 218. DENMARK GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 219. DENMARK GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 220. DENMARK GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 221. DENMARK GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. DENMARK GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. DENMARK GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. DENMARK GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. QATAR GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. QATAR GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. QATAR GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 238. QATAR GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 239. QATAR GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 240. QATAR GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 241. QATAR GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. QATAR GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. QATAR GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. QATAR GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. FINLAND GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. FINLAND GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. FINLAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 248. FINLAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 249. FINLAND GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 250. FINLAND GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 251. FINLAND GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. FINLAND GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. FINLAND GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FINLAND GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EGYPT GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. EGYPT GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. EGYPT GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 278. EGYPT GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 279. EGYPT GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 280. EGYPT GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 281. EGYPT GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. EGYPT GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. EGYPT GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. EGYPT GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. TURKEY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. TURKEY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. TURKEY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 288. TURKEY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 289. TURKEY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 290. TURKEY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 291. TURKEY GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. TURKEY GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. TURKEY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. TURKEY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. NORWAY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NORWAY GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NORWAY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 308. NORWAY GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 309. NORWAY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 310. NORWAY GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 311. NORWAY GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NORWAY GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NORWAY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NORWAY GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. POLAND GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. POLAND GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. POLAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 318. POLAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 319. POLAND GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 320. POLAND GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 321. POLAND GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. POLAND GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. POLAND GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. POLAND GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. SWITZERLAND GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 346. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 347. CHINA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 348. CHINA GALACTOSEMIA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 349. CHINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 350. CHINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 351. CHINA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 352. CHINA GALACTOSEMIA MARKET SIZE, BY THERAPEUTIC SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 353. CHINA GALACTOSEMIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. CHINA GALACTOSEMIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. CHINA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. CHINA GALACTOSEMIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. INDIA GALACTOSEMIA MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Galactosemia market report include:
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • BioMarin Pharmaceutical Inc.
  • Ultragenyx Pharmaceutical Inc.
  • Vivet Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 570.45 Million
Forecasted Market Value ( USD ) by 2030 $ 803.11 Million
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Galactosemia- Pipeline Insight, 2025 - Product Image

Galactosemia- Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Diabetic nephropathy Market - Global Forecast 2025-2030 - Product Image

Diabetic nephropathy Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Amino Acid Metabolism Disorders Treatment Market - Global Forecast 2025-2030 - Product Image

Amino Acid Metabolism Disorders Treatment Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Metabolic Disorder Therapeutics Market Size, Share & Trends Analysis Report By Disease, By Therapy, By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Metabolic Disorder Therapeutics Market Size, Share & Trends Analysis Report By Disease, By Therapy, By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Therapy, By Type, By Disease, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Therapy, By Type, By Disease, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Market

Galactosemia is a rare genetic disorder that affects the metabolism of galactose, a sugar found in dairy products and other foods. Endocrine and Metabolic Disorders Drugs are used to treat this disorder. These drugs are used to reduce the amount of galactose in the body, as well as to reduce the symptoms associated with the disorder. Common drugs used to treat galactosemia include galactose-1-phosphate uridyltransferase (GALT) enzyme replacement therapy, galactose-restricted diet, and lactose-free diet. The Galactosemia Drug market is a niche market, with a limited number of drugs available to treat the disorder. The market is expected to grow in the coming years, as more research is conducted into the disorder and new treatments are developed. Some companies in the Galactosemia Drug market include Sanofi, Pfizer, Novartis, and Merck. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.